TABLE 2.
Synthetic drugs acting on the CNS and their possible limitation.
| Therapeutic class | Pharmacological Use | Limitation/Possible side effect | Examples | References |
|---|---|---|---|---|
| Antidepressants | CNS stimulants; anticholinergic | Tricyclics may promote dry mouth, impaired vision, tachycardia, and cardiac arrythmias | Monoamine oxidase inhibitors and tricyclic antidepressants | (Walsh, 1979; Livingston and Livingston, 1996; Youdim et al., 2006) |
| Antipsychotics | Relieve anxiety and thought disturbances | These medications have the potential to induce drowsiness, hypothermia, hypotension, and lowering in seizure threshold. | Butyrophenones and phenothiazines | (Janssen, 1965; Martin et al., 1992) |
| Antiemetics | Relieve nausea and vomiting | Antihistamines are the only treatments that are recommended for divers to use in order to prevent motion sickness; nevertheless, the sleepiness generated by these medications might induce a reduction in cognitive ability. | Anticholinergics and antihistamines | Williams et al. (1988) |
| Anxiolytics | Relieve anxiety; depress CNS | Anxiolytic medications often produce sleepiness, lethargy, disorientation, and hypotension, all of which have the potential to be catastrophic in the water. | Benzodiazepines | (Groner-Strauss and Strauss, 1976; Greenblatt et al., 1983; Stewart, 2005) |
| CNS Stimulants | ncrease alertness; inhibit fatigue; suppress appetite; mood elevation | These may bring on symptoms such as exhilaration, increased perspiration, anxiety, and panic attacks. | Amphetamines | (Cheshire et al., 2001; Fleckenstein et al., 2007; Carvalho et al., 2012) |
| Hypnotics | Depress CNS and induce sleep | It may produce drowsiness, asthenia (weakness), headache, and aeuromuscular and skeletal weakness | Barbiturates | (Vermeeren, 2004; Charney et al., 2006) |